Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evangéline Pillebout

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Nephrologie & Therapeutique|January 7, 2014
[Hepatorenal syndrome]Evangéline Pillebout
Presse Medicale (Paris, France : 1983)|August 6, 2008
[Adult Henoch-Schönlein purpura]Evangéline Pillebout
Seminars in Nephrology|March 11, 2025
IgA Vasculitis and IgA Nephropathy: Two Sides of the Same Coin?Evangéline Pillebout
Nephrologie & Therapeutique|June 22, 2016
[IgA nephropathy]Evangéline Pillebout, Jérôme Vérine
Seminars in Immunopathology|June 25, 2021
IgA vasculitisEvangéline Pillebout, Cord Sunderkötter
Nephrologie & Therapeutique|April 20, 2010
[Glomerulonephritis with IgA mesangial deposits]Evangéline Pillebout, Dominique Nochy
La Revue Du Praticien|June 6, 2008
[Henoch-Schönlein purpura]Evangéline Pillebout, Patrick Niaudet
Frontiers in Medicine|March 20, 2023
Pathophysiology and clinical manifestations of immune complex vasculitidesCord Sunderkötter, Linda Golle, Evangéline Pillebout, et al.
Kidney International|May 28, 2010
Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch Schönlein PurpuraEvangéline Pillebout, Corinne Alberti, Loic Guillevin, et al.
Journal of the American Society of Nephrology : JASN|April 19, 2002
Henoch-Schönlein Purpura in adults: outcome and prognostic factorsEvangéline Pillebout, Eric Thervet, Gary Hill, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Nephrologie & Therapeutique|January 7, 2014
[Hepatorenal syndrome]Evangéline Pillebout
Presse Medicale (Paris, France : 1983)|August 6, 2008
[Adult Henoch-Schönlein purpura]Evangéline Pillebout
Seminars in Nephrology|March 11, 2025
IgA Vasculitis and IgA Nephropathy: Two Sides of the Same Coin?Evangéline Pillebout
Nephrologie & Therapeutique|June 22, 2016
[IgA nephropathy]Evangéline Pillebout, Jérôme Vérine
Seminars in Immunopathology|June 25, 2021
IgA vasculitisEvangéline Pillebout, Cord Sunderkötter
Nephrologie & Therapeutique|April 20, 2010
[Glomerulonephritis with IgA mesangial deposits]Evangéline Pillebout, Dominique Nochy
La Revue Du Praticien|June 6, 2008
[Henoch-Schönlein purpura]Evangéline Pillebout, Patrick Niaudet
Frontiers in Medicine|March 20, 2023
Pathophysiology and clinical manifestations of immune complex vasculitidesCord Sunderkötter, Linda Golle, Evangéline Pillebout, et al.
Kidney International|May 28, 2010
Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch Schönlein PurpuraEvangéline Pillebout, Corinne Alberti, Loic Guillevin, et al.
Journal of the American Society of Nephrology : JASN|April 19, 2002
Henoch-Schönlein Purpura in adults: outcome and prognostic factorsEvangéline Pillebout, Eric Thervet, Gary Hill, et al.
Pageof 4